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Objectives: It is thought prior endovascular abdominal aortic aneu-
rysm (AAA) repair (EVAR) confers protective effects in the setting of
ruptured AAA (RAAA). This study compares outcomes of RAAA repairs in
patients with and without prior EVAR.
Methods: A retrospective review identified 20 patients with (Group 1)
and 219 patients without (Group 2) the history of EVAR who presented
with RAAA from January 2001 to December 2008. EVARs of de novo
RAAAs were excluded. Patient characteristics and pre-, intra-, and postop-
erative variables were collected from the medical record. Logistic regression
was used to identify factors contributing to morbidity and mortality, and
Kaplan-Meier method to estimate the late survival rates.
Results: Mean age was 76.6 years (range, 59-92 years) in Group 1 and
74.6 years (range, 45-92 years) in Group 2 (P .32). Males comprised 84% of
patients in Group 1 and 77% inGroup 2 (P .57). Hemodynamic instability at
RAAA occurred with similar frequency, 48% vs 55%, respectively. Mean time
fromEVAR toRAAAwas 3.8 years (range, 0.3-7.8 years). The devices involved
were Ancure (GuidantCorporation, SantaClara, Calif) (9), AneuRx (Medtron-
ics, Minneapolis, Minn) (5), Zenith (Cook Medical, Bloomington, Ind) (4),
and Excluder (WL Gore and Associates, Inc, Flagstaff, Ariz) (2). Endoleaks
(EL) present at RAAA, confirmed by computed tomography (CT)/operative
findings, were proximal (Ia) in nine and distal (Ib) in five patients. Type III and
IV were seen in one patient each (5%). Multiple EL were seen in three patients
(Ia& III, Ib&II, Ib, II& IV inone patient each); inonepatient itwasunknown.
Fourteen patients had had a follow-up (F/U)CTprior toRAAA.On the last F/U
CT (obtained 0.1-3.9 years before rupture), AAAwas deemed stable in 10 patients
(no change in seven, decrease in three) and increasing in size in four, while ELwas
noted in three patients only. Most of the EL at RAAA was new. Open conversion
(OC)withpartial/completeendograft explantwasperformed in sevenpatients, and
11endovascular interventions (EI), nine extensions and twoEVARs, in10patients;
two patients underwent OC preceded by a failed EI. All patients in Group 2
underwent open repairs. No differences in operative mortality (36% vs 38%),
complication (44% vs 50%), and one-year survival rates (22% vs 48%) were noted
between Groups 1 and 2, respectively. Advanced age and preoperative cardiopul-
monary resuscitation were independent predictors of death.
Conclusions: RAAA remains a lethal problem in patients with and
without prior EVAR alike. The extant endograft provides neither acute nor
late survival benefits after RAAA repairs, while AAA sac and EL behave
capriciously. Vigilant surveillance after EVAR is crucial.
Bilateral Hypogastric Interruption is Safe when Needed During
EVAR: Outcomes of a Multicenter 135 Patient Study
Mehta M, Veith FJ, Roddy SP, Darling RC III, et al
Objectives: To analyze a multicenter experience of bilateral hypogas-
tric artery interruption (HAI) during endovascular aneurysm repair (EVAR)
and identify factors that might help minimize pelvic ischemic complications.
Methods: Over the past decade, 150 patients with complex aortoiliac
aneurysms required bilateral HAI during EVAR. All centers followed several
fundamental principles during EVAR and bilateral HAI; coils were placed at
the origins of the hypogastric arteries, aggressive catheter manipulation
within clot lined iliac aneurysms was avoided to prevent distal embolization
and interruption of pelvic collaterals, bilateral HAI were staged whenever
possible, the collateral medial and lateral iliac and femoral circumflex arteries
were preserved. Patients with prior pelvic radiation therapy and known
critical superior mesenteric artery (SMA) and celiac artery stenosis/occlu-
sions were excluded.
Results: Of 150 patients with bilateral HAI during EVAR, the mean
age was 78 years and the mean diameter of the aortic, common iliac artery,
and hypogastric artery aneurysm was 5.8 cm, 4.4 cm, and 4.1 cm, respec-
tively (subset analysis). In the immediate postoperative period, 57 (38%)
patients complained of buttock claudication, and six month follow-up,
only 13% of patients complained of persistent lifestyle disabling symptoms of
buttock claudication, and two (1.3%) patients underwent elective hypogas-
tric artery bypass and had full recovery from buttock claudication. None of
the patients developed ischemic colitis requiring colon resection, buttock
necrosis, or spinal cord ischemia. One (0.7%) patient that also required
placement of a Palmaz stent at the juxta-renal aorta for treatment of a type I
endoleak during EVAR developed multisystem organ failure, including
ischemic colitis, and died.
Conclusions: Our collective multicenter experience indicates that
bilateral HAI can be safe and accomplished with a limited morbidity and
mortality. When HAI is needed during EVAR, the fundamental principles
outlined above help to minimize complications of pelvic ischemia.
964Endovascular Management of Acute Aortic Dissections
O’Donnell S, Goetcheus A, Beavers F, Lowery R, Ricotta J
Objectives: Acute aortic dissection (AAD) is one of the most common
aortic emergencies that vascular specialists are asked to manage. Traditional
surgical interventions for cases complicated by malperfusion have resulted in
significant morbidity and mortality. With increasing availability of thoracic
endografts endovascular interventions for complicated AAD have become
more acceptable. We reviewed our experience with endovascular treatment
of AAD since January of 2005.
Methods:Medical records of patients admitted for AAD from January
1, 2005 to December 31, 2009 were entered into our vascular registry and
analyzed for risk factors, extent of dissection, type of management, fate of
the false lumen, complications, and survival. There were 249 admissions for
aortic dissections during the study period. Our study group included the 29
patients with complicated AAD who underwent endovascular intervention.
Results: There were 42 endovascular procedures performed on 29
patients during the study interval. Seventeen patients were female and the
average age was 54 years. Risk factors differed from the typical atheroscle-
rotic patient and was dominated by an 86.7% incidence of hypertension. A
history of recent cocaine use was present in four (14.3%) patients. The
average length of stay was 20 days (range, 1-196 days). All but one patient
had Stanford Type B dissections. Thoracic endografts were placed in 26
patients. Multiple procedures were required in seven patients. Morbidity
occurred in 55.2% of patients, with renal insufficiency being the most
prevalent in eight (27.6%) patients with one patient requiring permanent
dialysis. There were three neurologic events with two (6.9%) strokes and one
(3.4%) patient with temporary paraplegia. Three (10.3%) patients died in the
periprocedural period, two of which were ruptured dissections. Of the 10
CT scans available for review in follow-up, eight (80%) had complete
thrombosis of the thoracic false lumen.
Conclusions: Complicated AAD remains a challenging problem with
significant morbidity and mortality. However, our early experience with
endovascular management offers a favorable reduction in mortality from
historical controls.
Endovascular Repair of Combined Distal Arch and Extent in Thora-
coabdominal Aneurysm: Landing Zone Extension into the Aortic Arch
and Mesenteric Portion of the Abdominal Aorta
Brinster CJ, Szeto WY, Bavaria JE, Woo EY, Fairman RM, Jackson BM
Objectives:Thoracic endovascular aortic repair (TEVAR) has emerged
as a surgical alternative for patients at prohibitive risk for open repair. We
report a series of patients at a single institution with type I thoracoabdominal
aneurysms (TAAAs) who required coverage of the left subclavian (LSA) and
celiac artery to achieve aneurysmal exclusion during TEVAR.
Methods: Between August 2005 and April 2009, 219 patients under-
went TEVAR. Patients with type I TAAAs requiring coverage of the LSA
(zone 2) and celiac artery to achieve adequate proximal and distal fixation
were identified. Except when contraindicated by renal failure, all patients
underwent preoperative computed tomography angiography (CTA) to eval-
uate collateral circulation between the celiac and superior mesenteric artery
(SMA).
Results: Six of 219 (2.7%) patients undergoing TEVAR had type I
TAAAs that required proximal landing zone extension to zone 2 of the aortic
arch and distal landing zone extension into the mesenteric abdominal aorta
to include coverage of the celiac artery. There were twomale and four female
patients, and the mean age was 78.3 years (range, 68 to 83 years). The
average maximum aneurysmal diameter was 6.8 cm. All six patients under-
went elective LSA bypass prior to TEVAR with subsequent coil emboliza-
tion of the LSA remnant during TEVAR. In a mean follow-up of 21.2
months, there were no reported complications of paraplegia, stroke, en-
doleak, visceral ischemia, spinal ischemia, conversion to open revasculariza-
tion, left upper extremity ischemia, or aneurysm rupture.
Conclusions: Although TEVAR has evolved into a viable option in the
treatment of thoracic aortic aneurysms, there is little data to support distal
landing zone extension into the abdominal aorta, and there are no reported
series of TEVAR for type I TAAAs. This preliminary series suggests that
TEVAR can be utilized in the treatment of type I TAAAs, and that coverage
of the LSA and celiac artery to achieve aneurysmal exclusion is safe and viable
in select patients. Elective LSA revascularization and subsequent coil embo-
lization are useful adjuncts to reduce the risk of paraplegia and endoleak and
to maintain left upper extremity perfusion. Preoperative CTA and intraop-
erative angiography are essential to confirm SMA to celiac collateralization
prior to complete celiac interruption.
